Microsoft and healthcare technology provider Paige have started a relationship to fight cancer by building the world’s biggest image based artificial intelligence (AI) model for digital pathology and oncology.

Paige, who was the first company to receive FDA approval for a clinical AI application in digital pathology, will work with Microsoft to create a new AI model that will be the largest image-based AI model to date. The aim of the AI model is to capture the small details of cancer which can be used in the next generation of medical applications and computational biomarkers.

Discover B2B Marketing That Performs

Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.

Find out more

Desney Tan, Vice President and Managing Director, Microsoft Health Futures said: “By combining Microsoft’s world-class research and cloud infrastructure with Paige’s deep expertise and large-scale data, we are creating new AI models that will enable unprecedented insights into the pathology of cancer.” He added: “Unleashing the power of AI is a game changer in advancing healthcare to improve lives.”

Following the agreement, Paige plans to incorporate four million digitised microscopy slides across multiple types of cancer from its petabyte-scale archive of clinical data. They will also take advantage of Microsoft’s supercomputing infrastructure to train the technology. Azure will then be used to distribute the technology to hospitals and laboratories worldwide.

Thomas Fuchs, Chief Scientist at Paige said: “Paige technology already goes beyond what is humanly possible today and helps physicians deliver better cancer care with AI support. By realising the potential of generative AI at unprecedented scale, the Paige model collaboration with Microsoft is a milestone in the history of oncology. It opens a window into the microscopic world with extraordinary fidelity, allowing for not only much higher accuracy but completely novel capabilities,”.

According to a GlobalData report, the market for AI platforms for the entire healthcare industry will reach $4.3bn by 2024, up from $1.bn in 2019. This will be driven by the use of AI by healthcare providers and payers, which is forecast to reach $2.9bn by 2024.

GlobalData Strategic Intelligence

US Tariffs are shifting - will you react or anticipate?

Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.

By GlobalData

Medical Device Network Excellence Awards - Nominations Closed

Nominations are now closed for the Medical Device Network Excellence Awards. A big thanks to all the organisations that entered – your response has been outstanding, showcasing exceptional innovation, leadership, and impact

Excellence in Action
SC MEDICA’s minimally invasive, radiation free spinal facet fixation system, FFX® is transforming spinal pain management and improving outcomes for surgeons and patients alike. Learn how SC MEDICA’s award-winning technology is redefining standards in facet joint pain treatment.

Discover the Impact